Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-12-08

FDA Approved: NASCOBAL — Supplemental Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NASCOBAL (cyanocobalamin) from ENDO USA, Inc., updating the product labeling for vitamin B12 deficiency-related use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASCOBAL (cyanocobalamin)

Snippet

SUPPL AP for NASCOBAL (CYANOCOBALAMIN)